Achieve Life Sciences
Achieve Life Sciences develops cytisinicline, a small molecule for nicotine dependence treatment.
SCHEDULE 13GAug 17Latest SEC filing
Aug 14Latest story
Sign inSign inAchieve Life Sciences develops cytisinicline, a small molecule for nicotine dependence treatment.